Vironova has received the world’s first and only GMP certification for Electron Microscope Lab from Swedish Medical Products Agency
The Vironova team of Josefina Nilsson, Head EM services and Martin Ryner, Manager Strategic Development presented a webinar on the 11th April with over 200 people participating.
Two Vironova patent applications have successfully passed the international phase We’re very pleased to announce that our patent "A method for quantification of purity of sub-visible particle samples" has now passed the PCT (international patent...
The event at Cell & Gene Therapy in Amsterdam this week was a successful showcase for MiniTEM. Apart from our own activities at our booth and a presentation in the main program we also received an excellent testimonial from Hanna Lesch, Research and...
The Royal Swedish Academy of Engineering Sciences (Kungl. Ingenjörsvetenskapsakademien, IVA), Business Executives Council met on the 29th November for their annual meeting at which we are proud to announce that Vironova’s CEO, Mohammed Homman was...
We are proud to announce that Vironova has been awarded funding for a two-year research project entitled “Interactive visualization tools for verification and improvement of deep neural network predictions.” The project will stretch over two years...
A report entitled “State of the global biomanufacturing and bioprocessing industry 2017” was published in September 2017 by William Reed’s BioPharma-Reporter. The report is based on a state-of-the-industry survey, answered by more than 350 people,...
Vironova has published a new article on BioProcess International today together with our friends at FinVector Vision Therapies Oy, Finland. It's a detailed explanation of how MiniTEM can be used for gene therapy applications and well worth a read....
Slides with audio recording of the presentation by Mathieu Colomb-Delsuc, Senior Scientist Vironova. Now available on demand. Download the webinar by clicking the link below.
Deloitte’s Sweden Technology Fast 50 is a ranking of Sweden's 50 fastest growing technology companies, based on growth in net sales over the past four years. The rankings include both public and private companies, covering all types of technology,...
TEM analysis of purity, integrity and formulation changes in the production of viral vectors and vaccines
Harnessing the power of TEM and AI for rapid and routine analytical insights for gene therapy development
TEM image-based analysis of purity, integrity and formulation changes in the production of viral vectors and vaccines
Analytical insights with ViroTEM for gene therapy and vaccine development
Finding critical quality parameters using TEM-based image analysis
3rd Annual Gene Therapy Analytical Development Europe, May 30th - June 1st.
Visit our career site